Obagi Medical Products, Inc.
DelistedCIK 1375247fmd_0VPGRPK7M0XDK9W39E591B719WManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Mar 14, 2013, 13 periods
Latest annual · FY2012
Millions- Total revenues
- 121
- Gross profit
- 96
- Operating income
- 27
- Net income
- 17
- Free cash flow
- 17
Latest quarter · Q4 FY2012
Millions- Total revenues
- 30
- Gross profit
- 24
- Operating income
- 12
- Net income
- 7
- Free cash flow
- 13
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2009 to FY2012
- +5.1%
Obagi Medical Products, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2012 | FY2011 | Change | Source |
|---|---|---|---|---|
| Revenue | $120.7 million | $114.1 million | +5.8% | 10-K 2013-03-15 · proof |
| Gross profit | $95.6 million | $90.1 million | +6.2% | 10-K 2013-03-15 · proof |
| Operating income | $27.4 million | $16 million | +71.4% | 10-K 2013-03-15 · proof |
| Net income | $16.6 million | $10 million | +66% | 10-K 2013-03-15 · proof |
| Cash from operating activities | $20.4 million | $19.4 million | +5.3% | 10-K 2013-03-15 · proof |
| Free cash flow | $17.3 million | $18.9 million | -8.3% | 10-K 2013-03-15 · proof |
| Total assets | $82.1 million | $77.7 million | +5.7% | 10-K 2013-03-15 · proof |
| Total liabilities | $20.2 million | $16.8 million | +20.7% | 10-K 2013-03-15 · proof |
| Cash and cash equivalents | $34.6 million | $35 million | -1.4% | 10-K 2013-03-15 · proof |
- What was Obagi Medical Products, Inc.'s revenue in fiscal 2012?
- Obagi Medical Products, Inc. reported revenue of $120.7 million for fiscal 2012 (the year ended Dec 31, 2012), against $114.1 million the year before (+5.8%). Source: the 10-K filed with the SEC on Mar 15, 2013. SEC
- What was Obagi Medical Products, Inc.'s gross profit in fiscal 2012?
- Obagi Medical Products, Inc. reported gross profit of $95.6 million for fiscal 2012 (the year ended Dec 31, 2012), against $90.1 million the year before (+6.2%). Source: the 10-K filed with the SEC on Mar 15, 2013. SEC
- What was Obagi Medical Products, Inc.'s operating income in fiscal 2012?
- Obagi Medical Products, Inc. reported operating income of $27.4 million for fiscal 2012 (the year ended Dec 31, 2012), against $16 million the year before (+71.4%). Source: the 10-K filed with the SEC on Mar 15, 2013. SEC
- What was Obagi Medical Products, Inc.'s net income in fiscal 2012?
- Obagi Medical Products, Inc. reported net income of $16.6 million for fiscal 2012 (the year ended Dec 31, 2012), against $10 million the year before (+66%). Source: the 10-K filed with the SEC on Mar 15, 2013. SEC
- What was Obagi Medical Products, Inc.'s cash from operating activities in fiscal 2012?
- Obagi Medical Products, Inc. reported cash from operating activities of $20.4 million for fiscal 2012 (the year ended Dec 31, 2012), against $19.4 million the year before (+5.3%). Source: the 10-K filed with the SEC on Mar 15, 2013. SEC
- What was Obagi Medical Products, Inc.'s free cash flow in fiscal 2012?
- Obagi Medical Products, Inc. reported free cash flow of $17.3 million for fiscal 2012 (the year ended Dec 31, 2012), against $18.9 million the year before (-8.3%). Source: the 10-K filed with the SEC on Mar 15, 2013. SEC
- What are Obagi Medical Products, Inc.'s total assets?
- As of Dec 31, 2012, Obagi Medical Products, Inc. reported total assets of $82.1 million, against $77.7 million a year earlier (+5.7%). Source: the 10-K filed with the SEC on Mar 15, 2013. SEC
- What are Obagi Medical Products, Inc.'s total liabilities?
- As of Dec 31, 2012, Obagi Medical Products, Inc. reported total liabilities of $20.2 million, against $16.8 million a year earlier (+20.7%). Source: the 10-K filed with the SEC on Mar 15, 2013. SEC
- What are Obagi Medical Products, Inc.'s cash and cash equivalents?
- As of Dec 31, 2012, Obagi Medical Products, Inc. reported cash and cash equivalents of $34.6 million, against $35 million a year earlier (-1.4%). Source: the 10-K filed with the SEC on Mar 15, 2013. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1375247&period_type=annual&limit=5"Information only, not investment advice.